| Title |
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, March 2014
|
| DOI | 10.2147/tcrm.s30159 |
| Pubmed ID | |
| Authors |
Alexander GG Turpie |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 2 | 4% |
| Slovenia | 1 | 2% |
| Unknown | 49 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 9 | 17% |
| Student > Ph. D. Student | 8 | 15% |
| Researcher | 7 | 13% |
| Other | 5 | 10% |
| Student > Doctoral Student | 4 | 8% |
| Other | 12 | 23% |
| Unknown | 7 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 31 | 60% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 12% |
| Agricultural and Biological Sciences | 2 | 4% |
| Economics, Econometrics and Finance | 2 | 4% |
| Mathematics | 1 | 2% |
| Other | 3 | 6% |
| Unknown | 7 | 13% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 April 2014.
All research outputs
#14,599,159
of 25,371,288 outputs
Outputs from Therapeutics and Clinical Risk Management
#611
of 1,323 outputs
Outputs of similar age
#115,646
of 236,356 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#9
of 25 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,356 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.